Certified by Founder Lodge
NextPoint Therapeutics, Inc.
- ND
START UP
1 Disclosed Funding Rounds $42,500,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on a novel, validated
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 15 ,2024 | Series B | $42,500,000 |
Sixty Degree Capital
Catalio Capital Management
Leaps by Bayer
MPM BioImpact
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
